VRCA — Verrica Pharmaceuticals Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-06-15.
Performance
Technicals
Others in Healthcare
Measured signals that fired on VRCA
| date | signal | measured base rate |
|---|---|---|
| 2026-08-18 | Cluster buy: three or more insiders insider | +0.63% over 21 days · t = 1.84 · n = 3,050 not distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-18 | Kirby John J. Interim CFO | Open-market purchase | 5.0K | 4.93 | 24.6K |
| 2026-08-18 | Rosenberg Noah L. CMO | Open-market purchase | 2.0K | 4.92 | 10.0K |
| 2026-08-17 | Zawitz David Chief Operating Officer | Open-market purchase | 6.0K | 4.98 | 29.9K |
| 2026-08-17 | Rieger Jayson CEO and President | Open-market purchase | 5.0K | 4.91 | 24.6K |
| 2026-08-17 | Rosenberg Noah L. CMO | Open-market purchase | 4.2K | 4.91 | 20.6K |
| 2026-08-14 | Rieger Jayson CEO and President | Open-market purchase | 20.0K | 5.06 | 101.2K |
| 2025-12-23 | Kirby John J. Interim CFO | Grant or award | 10.0K | 0.00 | 0 |
| 2025-11-25 | Manning Paul B Director | Open-market purchase | 2.8M | 4.24 | 11.7M |
| 2025-11-25 | Manning Paul B Director | Open-market purchase | 1.4M | 4.24 | 5.8M |
| 2025-11-25 | Rieger Jayson CEO and President | Open-market purchase | 94.3K | 4.24 | 399.9K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Caligan Partners LP | 4.9M | 923.9K |
| Affinity Asset Advisors, LLC | 3.7M | 707.3K |
| CANNELL CAPITAL LLC | 3.6M | 685.1K |
| ARMISTICE CAPITAL, LLC | 2.7M | 518.2K |
| Velan Capital Investment Management LP | 2.5M | 471.6K |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.5M | 280.7K |
| VANGUARD CAPITAL MANAGEMENT LLC | 998.5K | 188.8K |
| DAFNA Capital Management LLC | 813.1K | 153.7K |
| MARSHALL WACE, LLP | 743.2K | 140.5K |
| GEODE CAPITAL MANAGEMENT, LLC | 735.0K | 138.9K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about VRCA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →